A Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis

NCT07417995 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis Arthritis

Interventions

DRUG: Biologic or targeted synthetic DMARD (b/tsDMARD)

Sponsor

Royal United Hospitals Bath NHS Foundation Trust

Collaborators

[object Object]